PetMed Express, Inc.

PETS Healthcare Pharmaceutical Retailers

PetMed Express, Inc.’s revenue for fiscal 2026 (year ended March 2026) was $179.0 million, down 21.1% from fiscal 2025. In the quarter to June 2026, revenue fell 19.9%, EPS grew 83.0% and free cash flow grew 38.6%, each against the same quarter a year earlier. Dividend growth for ten consecutive years; insiders bought in the last twelve months.

1.20 0.02 −1.64%
Market cap
$26.4M
P/E
0.0×
Fwd P/E
24.0×
Dividend yield
—
F-score
3/9
Altman Z
0.40
Beneish M
−4.77
Dividend safety
36/100
Jun '26 Mar '26 Dec '25 Sep '25 Older periods
ROE
(78.58%) (100.45%) (100.63%) (78.90%)

+8 more TTM periods

Piotroski F-Score
3 3 3 2
ROA
(33.73%) (49.84%) (55.74%) (44.67%)
ROIC
(194.08%) (487.12%) (630.14%) (439.47%)
Return on Tangible Assets
(239.60%) (320.82%) (304.68%) (176.87%)
Average Days of Receivables
3.69 3.89 3.04 3.62
Free Cash Flow per Share
(1.28) (1.58) (1.09) (0.75)
Free Cash Flow
(27.77) (33.01) (22.92) (15.68)
Other line items

Show all line items

Columns are period end dates